本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Inozyme Pharma

4.00
0.0000
成交量:- -
成交額:- -
市值:2.60億
市盈率:-2.38
高:4.00
開:4.00
低:4.00
收:4.00
資料載入中...
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/16

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/14

SEC問詢函

Form CORRESP - Correspondence
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/26

重要事件披露

Form 8-K - Current report
2023/08/11

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/28

重要事件披露

Form 8-K - Current report
2023/07/26

重要事件披露

Form 8-K - Current report
2023/06/30

SEC問詢函

Form CORRESP - Correspondence
2023/06/28

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/23

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]